Biblio

Export 1467 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
U
M. Asif Emran Emon, Kodamullil, A. Tom, Karki, R., Younesi, E., and Hofmann-Apitius, M., “Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 56, no. 2, pp. 677-686, 2017.
C. Lage, Suarez, A. Gonzalez, Pozueta, A., Riancho, J., Kazimierczak, M., Bravo, M., Bonilla, J. Jimenez, Torres, Mde Arcocha, Quirce, R., Banzo, I., Vázquez-Higuera, J. Luis, Rabinovici, G. D., Rodriguez-Rodriguez, E., and Sánchez-Juan, P., “Utility of Amyloid and FDG-PET in Clinical Practice: Differences Between Secondary and Tertiary Care Memory Units.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1025-1033, 2018.
M. F. Bergeron, Landset, S., Zhou, X., Ding, T., Khoshgoftaar, T. M., Zhao, F., Du, B., Chen, X., Wang, X., Zhong, L., Liu, X., and J Ashford, W., “Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1545-1558, 2020.
M. J. Lan, R Ogden, T., Kumar, D., Stern, Y., Parsey, R. V., Pelton, G. H., Rubin-Falcone, H., Pradhaban, G., Zanderigo, F., Miller, J. M., J Mann, J., and Devanand, D. P., “Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 60, no. 3, pp. 939-947, 2017.
A. Pons, LaMonica, H. M., Mowszowski, L., Köhler, S., Deckers, K., and Naismith, S. L., “Utility of the LIBRA Index in Relation to Cognitive Functioning in a Clinical Health Seeking Sample.”, J Alzheimers Dis, vol. 62, no. 1, pp. 373-384, 2018.
V
H. Shinagawa, Ohuchi, K., Goto, Y., Hashimoto, K., Kijima, H., Maekawa, S., Kurita, H., and Inden, M., “Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1011-1017, 2023.
H. Shinagawa, Ohuchi, K., Goto, Y., Hashimoto, K., Kijima, H., Maekawa, S., Kurita, H., and Inden, M., “Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1011-1017, 2023.
H. - W. Klafki, Hafermann, H., Bauer, C., Haussmann, U., Kraus, I., Schuchhardt, J., Muck, S., Scherbaum, N., and Wiltfang, J., “Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort.”, J Alzheimers Dis, vol. 54, no. 2, pp. 691-705, 2016.
H. - W. Klafki, Hafermann, H., Bauer, C., Haussmann, U., Kraus, I., Schuchhardt, J., Muck, S., Scherbaum, N., and Wiltfang, J., “Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort.”, J Alzheimers Dis, vol. 54, no. 2, pp. 691-705, 2016.
E. Stallard, Kociolek, A., Jin, Z., Ryu, H., Lee, S., Cosentino, S., Zhu, C., Gu, Y., Fernandez, K., Hernandez, M., Kinosian, B., and Stern, Y., “Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.”, J Alzheimers Dis, vol. 95, no. 1, pp. 93-117, 2023.
E. Stallard, Kociolek, A., Jin, Z., Ryu, H., Lee, S., Cosentino, S., Zhu, C., Gu, Y., Fernandez, K., Hernandez, M., Kinosian, B., and Stern, Y., “Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.”, J Alzheimers Dis, vol. 95, no. 1, pp. 93-117, 2023.
M. Müller, H Kuiperij, B., Versleijen, A. A. M., Chiasserini, D., Farotti, L., Baschieri, F., Parnetti, L., Struyfs, H., De Roeck, N., Luyckx, J., Engelborghs, S., Claassen, J. A., and Verbeek, M. M., “Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1321-33, 2016.
S. Westwood, Baird, A. L., Anand, S. N., Nevado-Holgado, A. J., Kormilitzin, A., Shi, L., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Baker, S., Buckley, N. J., Kate, M. Ten, Scheltens, P., Teunissen, C. E., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Sala, I., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Freund-Levi, Y., Frölich, L., Dobricic, V., Legido-Quigley, C., Bertram, L., Barkhof, F., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, and Lovestone, S., “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
S. Westwood, Baird, A. L., Anand, S. N., Nevado-Holgado, A. J., Kormilitzin, A., Shi, L., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Baker, S., Buckley, N. J., Kate, M. Ten, Scheltens, P., Teunissen, C. E., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Sala, I., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Freund-Levi, Y., Frölich, L., Dobricic, V., Legido-Quigley, C., Bertram, L., Barkhof, F., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, and Lovestone, S., “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
S. Westwood, Baird, A. L., Anand, S. N., Nevado-Holgado, A. J., Kormilitzin, A., Shi, L., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Baker, S., Buckley, N. J., Kate, M. Ten, Scheltens, P., Teunissen, C. E., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Sala, I., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Freund-Levi, Y., Frölich, L., Dobricic, V., Legido-Quigley, C., Bertram, L., Barkhof, F., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, and Lovestone, S., “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
H. Jin Ryu, Kim, M., Moon, Y., Choi, Y., Han, J. - Y., Galvin, J. E., and Han, S. - H., “Validation of the Korean Version of the Lewy Body Composite Risk Score (K-LBCRS).”, J Alzheimers Dis, vol. 55, no. 4, pp. 1395-1401, 2017.
O. Anna Skrobot, McKnight, A. Jayne, Passmore, P. Anthony, Seripa, D., Mecocci, P., Panza, F., Kalaria, R., Wilcock, G., Munafò, M., Erkinjuntti, T., Karhunen, P., Pessi, T., Martiskainen, M., Love, S., and Kehoe, P. Gavin, “A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort.”, J Alzheimers Dis, vol. 53, no. 3, pp. 981-9, 2016.
O. Anna Skrobot, McKnight, A. Jayne, Passmore, P. Anthony, Seripa, D., Mecocci, P., Panza, F., Kalaria, R., Wilcock, G., Munafò, M., Erkinjuntti, T., Karhunen, P., Pessi, T., Martiskainen, M., Love, S., and Kehoe, P. Gavin, “A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort.”, J Alzheimers Dis, vol. 53, no. 3, pp. 981-9, 2016.
O. Anna Skrobot, McKnight, A. Jayne, Passmore, P. Anthony, Seripa, D., Mecocci, P., Panza, F., Kalaria, R., Wilcock, G., Munafò, M., Erkinjuntti, T., Karhunen, P., Pessi, T., Martiskainen, M., Love, S., and Kehoe, P. Gavin, “A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort.”, J Alzheimers Dis, vol. 53, no. 3, pp. 981-9, 2016.
K. Krishnan, Machulda, M. M., Whitwell, J. L., Butts, A. M., Duffy, J. R., Strand, E. A., Senjem, M. L., Spychalla, A. J., Jack, C. R., Lowe, V. J., and Josephs, K. A., “Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1019-1029, 2017.
P. Wijesinghe, Shankar, S. K., Yasha, T. C., Gorrie, C., Amaratunga, D., Hulathduwa, S., K Kumara, S., Samarasinghe, K., Suh, Y. - H., Steinbusch, H. W. M., and K De Silva, R. D., “Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1607-1618, 2016.
Y. Kim, Jang, H., Kim, S. Joo, Cho, S. Hyun, Kim, S. Eun, Kim, S. Tae, Kim, H. Jin, Moon, S. Hwan, Ewers, M., Im, K., Kwon, H., Na, D. L., and Seo, S. Won, “Vascular Effects on Depressive Symptoms in Cognitive Impairment.”, J Alzheimers Dis, vol. 65, no. 2, pp. 597-605, 2018.
Y. Kim, Jang, H., Kim, S. Joo, Cho, S. Hyun, Kim, S. Eun, Kim, S. Tae, Kim, H. Jin, Moon, S. Hwan, Ewers, M., Im, K., Kwon, H., Na, D. L., and Seo, S. Won, “Vascular Effects on Depressive Symptoms in Cognitive Impairment.”, J Alzheimers Dis, vol. 65, no. 2, pp. 597-605, 2018.
Y. Kim, Jang, H., Kim, S. Joo, Cho, S. Hyun, Kim, S. Eun, Kim, S. Tae, Kim, H. Jin, Moon, S. Hwan, Ewers, M., Im, K., Kwon, H., Na, D. L., and Seo, S. Won, “Vascular Effects on Depressive Symptoms in Cognitive Impairment.”, J Alzheimers Dis, vol. 65, no. 2, pp. 597-605, 2018.
Y. Kim, Jang, H., Kim, S. Joo, Cho, S. Hyun, Kim, S. Eun, Kim, S. Tae, Kim, H. Jin, Moon, S. Hwan, Ewers, M., Im, K., Kwon, H., Na, D. L., and Seo, S. Won, “Vascular Effects on Depressive Symptoms in Cognitive Impairment.”, J Alzheimers Dis, vol. 65, no. 2, pp. 597-605, 2018.

Pages